Report Detail
Global Heart Failure Drugs Market Research Report 2019
- RnM3123376 |
- 14 March, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Pharma & Healthcare
The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast period. Based on the drug class the market can be segmented into Beta blockers, ARBs, and ACE inhibitors. Angiotensin II receptor blockers (ARB) are a group of pharmaceuticals that modify the renin-angiotensin system. The heart disease drugs market is experiencing growth in the ARBs segment because it reduces the risk of death caused by heart failure and minimizes the chance of hospitalization of people with heart failure.
The latest trend gaining momentum in the market is investment inclination toward developing countries. Countries such as India, China, and Brazil are turning out to be some of the most attractive countries for pharmaceutical companies across the globe. Many factors such as huge share of global population and rising geriatric population are leading to the high growth of healthcare sector in the developing countries. In addition, the rising cases of lifestyle disorders such as obesity and diabetes also contribute to higher heart failure cases in the region.
One of the major drivers for this market is rising geriatric population. A large number of health problems are associated with the rising age, and CVDs are major among them. As a person gets older, the blood vessels become less flexible, thus making it difficult for the blood to flow through them. Rising age accompanied by other factors such as lifestyle-oriented diseases and smoking increases the risk of CVDs, especially heart failure. Heart failure in the geriatric population will continue to be a rising health burden globally, as this population represents the majority of the heart failure patients. Hence, rising geriatric population drives the demand for heart failure drugs during the forecast period.
The global Heart Failure Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Heart Failure Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heart Failure Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Amgen
AstraZeneca
Bayer
Novartis
Gilead
GlaxoSmithKline
Pfizer
Teva Pharmaceutical industries
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Beta Blockers
ARBs
ACE Inhibitors
Segment by Application
Hospital
Pharmacy
Others
Table of Contents
Executive Summary
1 Heart Failure Drugs Market Overview
- 1.1 Product Overview and Scope of Heart Failure Drugs
- 1.2 Heart Failure Drugs Segment by Type
- 1.2.1 Global Heart Failure Drugs Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Beta Blockers
- 1.2.3 ARBs
- 1.2.4 ACE Inhibitors
- 1.3 Heart Failure Drugs Segment by Application
- 1.3.1 Heart Failure Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Pharmacy
- 1.3.4 Others
- 1.4 Global Heart Failure Drugs Market by Region
- 1.4.1 Global Heart Failure Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Heart Failure Drugs Market Size
- 1.5.1 Global Heart Failure Drugs Revenue (2014-2025)
- 1.5.2 Global Heart Failure Drugs Production (2014-2025)
2 Global Heart Failure Drugs Market Competition by Manufacturers
- 2.1 Global Heart Failure Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Heart Failure Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Heart Failure Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Heart Failure Drugs Production Sites, Area Served, Product Types
- 2.5 Heart Failure Drugs Market Competitive Situation and Trends
- 2.5.1 Heart Failure Drugs Market Concentration Rate
- 2.5.2 Heart Failure Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Heart Failure Drugs Production Market Share by Regions
- 3.1 Global Heart Failure Drugs Production Market Share by Regions
- 3.2 Global Heart Failure Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Heart Failure Drugs Production
- 3.4.1 North America Heart Failure Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Heart Failure Drugs Production
- 3.5.1 Europe Heart Failure Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Heart Failure Drugs Production (2014-2019)
- 3.6.1 China Heart Failure Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Heart Failure Drugs Production (2014-2019)
- 3.7.1 Japan Heart Failure Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Heart Failure Drugs Consumption by Regions
- 4.1 Global Heart Failure Drugs Consumption by Regions
- 4.2 North America Heart Failure Drugs Consumption (2014-2019)
- 4.3 Europe Heart Failure Drugs Consumption (2014-2019)
- 4.4 China Heart Failure Drugs Consumption (2014-2019)
- 4.5 Japan Heart Failure Drugs Consumption (2014-2019)
5 Global Heart Failure Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Heart Failure Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Heart Failure Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Heart Failure Drugs Price by Type (2014-2019)
- 5.4 Global Heart Failure Drugs Production Growth by Type (2014-2019)
6 Global Heart Failure Drugs Market Analysis by Applications
- 6.1 Global Heart Failure Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Heart Failure Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Heart Failure Drugs Business
- 7.1 Amgen
- 7.1.1 Amgen Heart Failure Drugs Production Sites and Area Served
- 7.1.2 Heart Failure Drugs Product Introduction, Application and Specification
- 7.1.3 Amgen Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 AstraZeneca
- 7.2.1 AstraZeneca Heart Failure Drugs Production Sites and Area Served
- 7.2.2 Heart Failure Drugs Product Introduction, Application and Specification
- 7.2.3 AstraZeneca Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Bayer
- 7.3.1 Bayer Heart Failure Drugs Production Sites and Area Served
- 7.3.2 Heart Failure Drugs Product Introduction, Application and Specification
- 7.3.3 Bayer Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Novartis
- 7.4.1 Novartis Heart Failure Drugs Production Sites and Area Served
- 7.4.2 Heart Failure Drugs Product Introduction, Application and Specification
- 7.4.3 Novartis Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Gilead
- 7.5.1 Gilead Heart Failure Drugs Production Sites and Area Served
- 7.5.2 Heart Failure Drugs Product Introduction, Application and Specification
- 7.5.3 Gilead Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 GlaxoSmithKline
- 7.6.1 GlaxoSmithKline Heart Failure Drugs Production Sites and Area Served
- 7.6.2 Heart Failure Drugs Product Introduction, Application and Specification
- 7.6.3 GlaxoSmithKline Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Pfizer
- 7.7.1 Pfizer Heart Failure Drugs Production Sites and Area Served
- 7.7.2 Heart Failure Drugs Product Introduction, Application and Specification
- 7.7.3 Pfizer Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Teva Pharmaceutical industries
- 7.8.1 Teva Pharmaceutical industries Heart Failure Drugs Production Sites and Area Served
- 7.8.2 Heart Failure Drugs Product Introduction, Application and Specification
- 7.8.3 Teva Pharmaceutical industries Heart Failure Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
8 Heart Failure Drugs Manufacturing Cost Analysis
- 8.1 Heart Failure Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Heart Failure Drugs
- 8.4 Heart Failure Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Heart Failure Drugs Distributors List
- 9.3 Heart Failure Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Heart Failure Drugs Market Forecast
- 11.1 Global Heart Failure Drugs Production, Revenue Forecast
- 11.1.1 Global Heart Failure Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Heart Failure Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Heart Failure Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Heart Failure Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Heart Failure Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Heart Failure Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Heart Failure Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Heart Failure Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Heart Failure Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Heart Failure Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Heart Failure Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Heart Failure Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Heart Failure Drugs Consumption Forecast (2019-2025)
- 11.4 Global Heart Failure Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Heart Failure Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Heart Failure Drugs . Industry analysis & Market Report on Heart Failure Drugs is a syndicated market report, published as Global Heart Failure Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Heart Failure Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
